TAKEDA PHARMA. 20/32TAKEDA PHARMA. 20/32TAKEDA PHARMA. 20/32

TAKEDA PHARMA. 20/32

No trades
See on Supercharts

Key terms


Outstanding amount
‪1.00 B‬EUR
Face value
1,000.00EUR
Minimum denomination
100,000.00EUR
Coupon
1.38% (Fixed)
Coupon frequency
Annual
Yield to maturity
3.25%
Maturity date
Jul 9, 2032
Term to maturity
7 years

About TAKEDA PHARMA. 20/32


Sector
Health Technology
Home page
Issue date
Jul 9, 2020
ISIN
XS2197349645
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.